Trials / Recruiting
RecruitingNCT03535142
Prognostic Significance of Fatty Liver Disease in Bariatric Patients
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,200 (estimated)
- Sponsor
- Esbjerg Hospital - University Hospital of Southern Denmark · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective non-randomized intervention case control study on patients with a BMI \> 35. The intervention group/cases (n=600) is comprised of bariatric patients who undergo bariatric surgery and the control group (n=600) of age, weight and comorbidity matched patients who choose not to undergo bariatric surgery. The overall aim is to examine prevalence of the spectrum of fatty liver disease (NAFLD) in these patients and the prognostic significance of NAFLD.
Conditions
- Non-Alcoholic Fatty Liver Disease
- Metabolic Encephalopathy
- Obesity, Morbid
- Non-alcoholic Steatohepatitis
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Bariatric surgery | Roux en y gastric bypass or gastric sleeve operation |
Timeline
- Start date
- 2018-08-15
- Primary completion
- 2035-06-01
- Completion
- 2038-04-01
- First posted
- 2018-05-24
- Last updated
- 2025-03-05
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03535142. Inclusion in this directory is not an endorsement.